11 results
6-K
TAK
Takeda Pharmaceutical Co
7 Jun 24
Current report (foreign)
6:07am
link pay with performance and long-term shareholder value creation. A significant proportion of the Internal Directors’ compensation is in the form
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
29 May 24
Current report (foreign)
6:29am
FOR PERFORMANCE PHILOSOPHY AND OBJECTIVES Our executive compensation strategy is designed to closely link pay with performance and long-term shareholder … compensation programs are designed to be globally competitive and performance-oriented, while also considering local market factors. COMPENSATION PAY
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
6 Jul 23
Current report (foreign)
6:18am
to be globally competitive and performance- oriented, while also considering local market factors. We closely link pay with performance and long-term
6-K
TAK
Takeda Pharmaceutical Co
30 May 23
Current report (foreign)
6:20am
also considering local market factors.
COMPENSATION PAY FOR PERFORMANCE PHILOSOPHY AND OBJECTIVES
Our executive compensation strategy is designed … to closely link pay with performance and long-term shareholder value creation while minimizing excessive risk-taking. To help us accomplish
6-K
TAK
Takeda Pharmaceutical Co
31 May 22
Current report (foreign)
6:18am
to be globally competitive and performance-oriented, while also considering local market factors.
COMPENSATION PAY FOR PERFORMANCE PHILOSOPHY … AND OBJECTIVES
Our executive compensation strategy is designed to closely link pay with performance and increases in long-term shareholder value while
6-K
b8vp3u31ip z986o0
6 Aug 21
Current report (foreign)
6:10am
6-K
EX-99.1
e2qtuhrq6h a9
21 Jun 21
Current report (foreign)
6:05am
6-K
EX-99.1
zgl4m
28 May 21
Current report (foreign)
6:07am
6-K
sh4lofm uh6mxx
27 May 20
Current report (foreign)
6:13am
6-K
7d1thxw
17 Jun 19
Current report (foreign)
6:08am
6-K
iwx8m
14 Jun 19
Current report (foreign)
6:26am
- Prev
- 1
- Next